HALO logo
halo search icon
Jazz Pharmaceuticals Public Limited Company
Jazz Pharmaceuticals Public Limited Company
JAZZ · NAS

Jazz Pharmaceuticals Public Limited Company

US$239.40

Price Arrow0.39 (0.163%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEngulfing Bullish (Realtime)HALO AllHALO Capital EfficiencyHALO Earnings MomentumHALO GARPHALO Growth+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Jazz Pharmaceuticals Public Limited Company Overview

JAZZ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About JAZZ

icon

Telephone

353.1.634.7800

icon

Address

5th Floor, Waterloo Road, Waterloo Exchange, Dublin 4

Description

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

JAZZ Price Chart

Key Stats

Market Cap

US$15.00B

PE

21.10

EV/EBITDA

9.2

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 105 - 242.18

Trade Value (12mth)

US$36,301,017.00

1 week

4.48%

1 month

18.09%

YTD

38.04%

1 year

121.69%

All time high

242.18

Key Fundamentals

EPS 3 yr Growth

63.00%

EBITDA Margin

33.90%

Operating Cashflow

$1,356m

Free Cash Flow Return

14.30%

ROIC

-3.80%

Interest Coverage

5.20

Quick Ratio

1.70

Other Data

Shares Outstanding (Fully Diluted)

66m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

JAZZ Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
06 May 26

JAZZ Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock6.559.06-5.84locklocklock
EPS (Fully Diluted)
$locklocklocklock6.18.65-5.84locklocklock
Growth
%locklocklocklock282.938.2-164.5locklocklock
PE
Xlocklocklocklock20.214.221.1locklocklock
EV/EBITDA
Xlocklocklocklock108.19.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
The current share price of Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) is USD$239.40.
What is the 52-week high share price for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
The 52-week high share price for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) is USD$242.18.
What is the 52-week low share price for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
The 52-week low share price for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) is USD$105.00.
What is the dividend yield for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) does not pay a dividend.
What was Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) last dividend payment?
Halo FAQ
Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) does not pay a dividend.
What is the franking level for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) has a franking level of 0.00%.
In which sector is Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) classified?
Halo FAQ
Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS)?
Halo FAQ
The current P/E ratio for Jazz Pharmaceuticals Public Limited Company (JAZZ:NAS) is 21.10.

See beyond the curve.

One solution for research, investing and portfolio management.